Skip to the content Skip to the Navigation
O-Force Co., Ltd
  • HOME
  • ABOUT
  • Catalytide Research Lab
    • Catalytide Research Lab
    • Research Projects
    • Research Progress
    • Research Activities
  • Pharmacy
  • Careers
  • Contact Us
    • Contact Us
    • Q & A
  • 日本語
  • English

5/16, 2024 O-Force research members published in Biomolecules that a small peptide consisting of five amino acids degrades amyloid beta (Aβ42), which is implicated in the development of Alzheimer's disease.

  1. HOME
  2. 5/16, 2024 O-Force research members published in Biomolecules that a small peptide consisting of five amino acids degrades amyloid beta (Aβ42), which is implicated in the development of Alzheimer's disease.

Title: SKGQA, a Peptide Derived from the ANA/BTG3 Protein, Cleaves Amyloid-β with Proteolytic Activity

ANA-SA5, a small peptide composed of 5 amino acids, has new potential for treating Alzheimer's disease.

You can also listen to the audio summary of this paper.
Audio Abstract 1 (10 min length) or Audio Abstract 2 (30 min length)

  • HOME
  • ABOUT
  • Catalytide Research Lab
  • Pharmacy
  • Careers
  • Contact Us
  • 日本語
  • English

Copyright © O-Force Co., Ltd All Rights Reserved.

Powered by WordPress with Lightning Theme & VK All in One Expansion Unit

MENU
  • HOME
  • ABOUT
  • Catalytide Research Lab
    • Catalytide Research Lab
    • Research Projects
    • Research Progress
    • Research Activities
  • Pharmacy
  • Careers
  • Contact Us
    • Contact Us
    • Q & A
  • 日本語
  • English
PAGE TOP